Sonnet Biotherapeutics Holdings Inc
General ticker "SONN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $9.0M
Sonnet Biotherapeutics Holdings Inc does not follow the US Stock Market performance with the rate: -39.7%.
Estimated limits based on current volatility of 5.0%: low 1.51$, high 1.67$
Factors to consider:
- Current price 79.0% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [12.59$, 46.25$]
- 2024-09-29 to 2025-09-29 estimated range: [6.85$, 22.53$]
Financial Metrics affecting the SONN estimates:
- Negative: Non-GAAP EPS, $ of -30 <= 0.10
- Negative: Operating profit margin, % of -99.22 <= 1.03
- Negative: Operating cash flow per share per price, % of -38.31 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.09 <= 1.31
- Negative: Industry operating profit margin (median), % of -98.38 <= 2.14
- Negative: Industry operating cash flow per share per price (median), % of -24.49 <= 3.85
Short-term SONN quotes
Long-term SONN plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $0.35MM | $0.15MM | $0.02MM |
| Operating Expenses | $30.02MM | $18.94MM | $11.87MM |
| Operating Income | $-29.67MM | $-18.79MM | $-11.85MM |
| Non-Operating Income | $-0.05MM | $-0.04MM | $4.41MM |
| R&D Expense | $21.44MM | $11.81MM | $5.74MM |
| Income(Loss) | $-29.72MM | $-18.83MM | $-7.44MM |
| Profit(Loss) | $-29.72MM | $-18.83MM | $-7.44MM |
| Stockholders Equity | $-2.54MM | $-0.23MM | $-0.49MM |
| Assets | $5.83MM | $5.43MM | $2.77MM |
| Operating Cash Flow | $-27.77MM | $-21.34MM | $-8.61MM |
| Capital expenditure | $0.90MM | $0.44MM | $0.00MM |
| Investing Cash Flow | $-0.81MM | $-0.44MM | $-0.01MM |
| Financing Cash Flow | $4.01MM | $21.01MM | $6.49MM |
| Earnings Per Share* | $-150.79 | $-18.14 | $-11.35 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.